[Rotavirus Vaccine. Statement of the Consultive Committee of Immunizations on behalf of The Chilean Infectious Diseases Society. March 2006].
The article briefly reviews the epidemiology of rotavirus infection and the scientific information of the rotavirus vaccines: Rotashield, withdrawn from the market due to its association with intussusception, Rotateq currently in an advanced phase of development, and Rotarix, recently licensed in Chile. Considering the available information, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases, summarizes its conclusions and makes recommendations for infants vaccination against rotavirus in our country.
Muñoz M
Alma
A
Abarca V
Katia
K
Luchsinger F
Vivian
V
Valenzuela B
M Teresa
MT
Jiménez de la J
Jorge
J
D026683:Advisory Committees; D000367:Age Factors; D000818:Animals; D002417:Cattle; D002677:Chile / Q000453:epidemiology; D017277:Drug Approval; D005759:Gastroenteritis / Q000821:virology; D006801:Humans; D007223:Infant; D007443:Intussusception / Q000209:etiology; D012400:Rotavirus Infections / Q000453:epidemiology / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D012955:Societies, Medical; D014613:Vaccines, Attenuated / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology
C492457:RIX4414 vaccine; C492535:RotaTeq; D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated